V020-4257 Screening compound: N-cyclohexyl-N-{[4-(2-methylphenyl)-1-{[2-(trifluoromethyl)phenyl]methyl}pyrrolidin-3-yl]methyl}benzamide

V020-4257 Screening compound: N-cyclohexyl-N-{[4-(2-methylphenyl)-1-{[2-(trifluoromethyl)phenyl]methyl}pyrrolidin-3-yl]methyl}benzamide
V020-4257 Screening compound: N-cyclohexyl-N-{[4-(2-methylphenyl)-1-{[2-(trifluoromethyl)phenyl]methyl}pyrrolidin-3-yl]methyl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-4257
N-cyclohexyl-N-{[4-(2-methylphenyl)-1-{[2-(trifluoromethyl)phenyl]methyl}pyrrolidin-3-yl]methyl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-4257

Molecular Formula

C33H37F3N2O (C33 H37 F3 N2 O)

Compound Name

N-cyclohexyl-N-{[4-(2-methylphenyl)-1-{[2-(trifluoromethyl)phenyl]methyl}pyrrolidin-3-yl]methyl}benzamide

IUPAC name

N-cyclohexyl-N-{[4-(2-methylphenyl)-1-{[2-(trifluoromethyl)phenyl]methyl}pyrrolidin-3-yl]methyl}benzamide

SMILES

Cc1c(C2C(CN(C3CCCCC3)C(c3ccccc3)=O)CN(Cc3c(C(F)(F)F)cccc3)C2)cccc1

InChI

InChI=1S/C33H37F3N2O/c1-24-12-8-10-18-29(24)30-23-37(20-26-15-9-11-19-31(26)33(34,35)36)21-27(30)22-38(28-16-6-3-7-17-28)32(39)25-13-4-2-5-14-25/h2,4-5,8-15,18-19,27-28,30H,3,6-7,16-17,20-23H2,1H3

InChI Key

PBHKFLMPTSNKMG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19922340

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

534.66

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

7.831

Distribution Coefficient, logD

6.790

Water Solubility, LogSw

-5.59

Polar Surface Area

19.116

Acid Dissociation Constant (pKa)

23.12

Base Dissociation Constant (pKb)

8.40

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

42.40

V020-4257 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Nervous system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V020-4257 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-4257?
Check Price and Availability of V020-4257, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-4257 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-4257
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-4257
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-4257 available by request